BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28685753)

  • 1. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
    Lista MJ; Martins RP; Billant O; Contesse MA; Findakly S; Pochard P; Daskalogianni C; Beauvineau C; Guetta C; Jamin C; Teulade-Fichou MP; Fåhraeus R; Voisset C; Blondel M
    Nat Commun; 2017 Jul; 8():16043. PubMed ID: 28685753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.
    Reznichenko O; Quillévéré A; Martins RP; Loaëc N; Kang H; Lista MJ; Beauvineau C; González-García J; Guillot R; Voisset C; Daskalogianni C; Fåhraeus R; Teulade-Fichou MP; Blondel M; Granzhan A
    Eur J Med Chem; 2019 Sep; 178():13-29. PubMed ID: 31173968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune system.
    Angrand G; Quillévéré A; Loaëc N; Dinh VT; Le Sénéchal R; Chennoufi R; Duchambon P; Keruzoré M; Martins RP; Teulade-Fichou MP; Fåhraeus R; Blondel M
    Nucleic Acids Res; 2022 Nov; 50(20):11799-11819. PubMed ID: 36350639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness.
    Lista MJ; Martins RP; Angrand G; Quillévéré A; Daskalogianni C; Voisset C; Teulade-Fichou MP; Fåhraeus R; Blondel M
    Microb Cell; 2017 Aug; 4(9):305-307. PubMed ID: 28913345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Cellulo Protein-mRNA Interaction Assay to Determine the Action of G-Quadruplex-Binding Molecules.
    Prado Martins R; Findakly S; Daskalogianni C; Teulade-Fichou MP; Blondel M; Fåhraeus R
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30501034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.
    Voisset C; Daskalogianni C; Contesse MA; Mazars A; Arbach H; Le Cann M; Soubigou F; Apcher S; Fåhraeus R; Blondel M
    Dis Model Mech; 2014 Apr; 7(4):435-44. PubMed ID: 24558096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
    Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
    PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale.
    Dinh VT; Loaëc N; Quillévéré A; Le Sénéchal R; Keruzoré M; Martins RP; Granzhan A; Blondel M
    Biochimie; 2023 Nov; 214(Pt A):57-68. PubMed ID: 37473831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.
    Mautner J; Pich D; Nimmerjahn F; Milosevic S; Adhikary D; Christoph H; Witter K; Bornkamm GW; Hammerschmidt W; Behrends U
    Eur J Immunol; 2004 Sep; 34(9):2500-9. PubMed ID: 15307182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.
    Tellam JT; Lekieffre L; Zhong J; Lynn DJ; Khanna R
    PLoS Pathog; 2012 Dec; 8(12):e1003112. PubMed ID: 23300450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
    Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
    J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.
    Chen YL; Liu CD; Cheng CP; Zhao B; Hsu HJ; Shen CL; Chiu SJ; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):243-8. PubMed ID: 24344309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA.
    Zheng AJL; Thermou A; Daskalogianni C; Malbert-Colas L; Karakostis K; Le Sénéchal R; Trang Dinh V; Tovar Fernandez MC; Apcher S; Chen S; Blondel M; Fahraeus R
    Nucleic Acids Res; 2022 Sep; 50(17):10110-10122. PubMed ID: 36107769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.
    Yin Y; Manoury B; Fåhraeus R
    Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.
    Tellam J; Connolly G; Green KJ; Miles JJ; Moss DJ; Burrows SR; Khanna R
    J Exp Med; 2004 May; 199(10):1421-31. PubMed ID: 15148340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
    Lee SP; Brooks JM; Al-Jarrah H; Thomas WA; Haigh TA; Taylor GS; Humme S; Schepers A; Hammerschmidt W; Yates JL; Rickinson AB; Blake NW
    J Exp Med; 2004 May; 199(10):1409-20. PubMed ID: 15148339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.